Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008736
Filing Date
2017-11-09
Accepted
2017-11-09 16:44:17
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q immu-20170930x10q.htm 10-Q 1477966
2 EX-10.2 immu-20170930ex102a57faf.htm EX-10.2 325635
3 EX-10.3 immu-20170930ex1035f6dcd.htm EX-10.3 87381
4 EX-31.1 immu-20170930ex311f94ce8.htm EX-31.1 15173
5 EX-31.2 immu-20170930ex3129d9fad.htm EX-31.2 15255
6 EX-32.1 immu-20170930ex321a07562.htm EX-32.1 11510
  Complete submission text file 0001558370-17-008736.txt   6990327

Data Files

Seq Description Document Type Size
7 EX-101.INS immu-20170930.xml EX-101.INS 1517174
8 EX-101.SCH immu-20170930.xsd EX-101.SCH 41912
9 EX-101.CAL immu-20170930_cal.xml EX-101.CAL 46602
10 EX-101.DEF immu-20170930_def.xml EX-101.DEF 189122
11 EX-101.LAB immu-20170930_lab.xml EX-101.LAB 378481
12 EX-101.PRE immu-20170930_pre.xml EX-101.PRE 332409
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 171191479
SIC: 2835 In Vitro & In Vivo Diagnostic Substances